These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A new class of orally active glycol renin inhibitors containing phenyllactic acid at P3. Hanson GJ; Baran JS; Lowrie HS; Russell MA; Sarussi SJ; Williams K; Babler M; Bittner SE; Papaioannou SE; Yang PC Biochem Biophys Res Commun; 1989 Apr; 160(1):1-5. PubMed ID: 2496685 [TBL] [Abstract][Full Text] [Related]
4. New modified heterocyclic phenylalanine derivatives. Incorporation into potent inhibitors of human renin. Ocain TD; Deininger DD; Russo R; Senko NA; Katz A; Kitzen JM; Mitchell R; Oshiro G; Russo A; Stupienski R J Med Chem; 1992 Mar; 35(5):823-32. PubMed ID: 1548674 [TBL] [Abstract][Full Text] [Related]
5. Desulfonylative radical ring closure onto aromatics. A modular route to benzazepin-2-ones and 5-arylpiperidin-2-ones. Charrier N; Liu Z; Zard SZ Org Lett; 2012 Apr; 14(8):2018-21. PubMed ID: 22463494 [TBL] [Abstract][Full Text] [Related]
6. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction. Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440 [TBL] [Abstract][Full Text] [Related]
14. Design of potent substrate-analogue inhibitors of canine renin. Hui KY; Siragy HM; Haber E Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972 [TBL] [Abstract][Full Text] [Related]
15. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions. Paruszewski R; Jaworski P; Bodnar M; Dudkiewicz-Wilczyńska J; Roman I Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1305-9. PubMed ID: 16204988 [TBL] [Abstract][Full Text] [Related]
16. Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin. Göschke R; Stutz S; Rasetti V; Cohen NC; Rahuel J; Rigollier P; Baum HP; Forgiarini P; Schnell CR; Wagner T; Gruetter MG; Fuhrer W; Schilling W; Cumin F; Wood JM; Maibaum J J Med Chem; 2007 Oct; 50(20):4818-31. PubMed ID: 17824679 [TBL] [Abstract][Full Text] [Related]
18. Design of rat renin inhibitory peptides. Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320 [TBL] [Abstract][Full Text] [Related]
19. New potential renin inhibitors with dipeptide replacements in the molecule. Winiecka I; Dudkiewicz-Wilczyńska J; Roman I; Paruszewski R Acta Pol Pharm; 2010; 67(4):367-74. PubMed ID: 20635532 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state. Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Etoh Y; Shimaoka I; Tsubaki A; Murakami M; Yamaguchi T Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]